The equity shares of Jajoo Rashmi Refractories are proposed to be listed on both, the NSE and the BSE, following the IPO.

The IPO consists entirely of a fresh issue of shares with a face value of ₹10, with no offer-for-sale component.

Jaipur-based Jajoo Rashmi Refractories, a manufacturer and exporter of ferro alloys critical for steel production, is gearing ...

Chronic migraine becomes “refractory” when preventive treatments don’t work to reduce the frequency of episodes. Treatment may include complementary therapies like neuromodulation.

RHI Magnesita India Ltd. key Products/Revenue Segments include Refractories, Income From Management Services, Sale of services and Other Operating Revenue for the year ending 31-Mar-2024.For the ...

las vegas 5 blackjack tables Positive Phase 2b results of innovative therapy for refractory multiple myeloma The latest news on the fourth batch of national procurement has been released Inventory of ...

batting line up of todays match Medical Representative Registration Management Measures officially released, prohibiting 7 types of behaviors Roche's glofitamab shows strong efficacy in treating ...

The IPO will be an entirely fresh issue of Rs 150 crore worth of shares by the company with no offer-for-sale component.

A seismic shift in pediatric medical care has arrived with the FDA’s approval of Ryoncil (remestemcel-L-rknd), a ...

Odronextamab is under clinical development by Regeneron Pharmaceuticals and currently in Phase II for Diffuse Large B-Cell Lymphoma.